You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 3, March 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (14)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic

Sodium Hyaluronate Increases the Fibrinolytic Response of Human Peritoneal Mesothelial Cells Exposed to Tumor Necrosis Factor {alpha}

Michel M. P. J. Reijnen, MD; Harry van Goor, MD, PhD; Peter Falk, BSc; Maria Hedgren, BSc; Lena Holmdahl, MD, PhD

Arch Surg. 2001;136:291-296.

Hypothesis  Sodium hyaluronate interferes with the fibrin degrading capacity of human peritoneal mesothelial cells exposed to tumor necrosis factor (TNF) {alpha}.

Design  Controlled laboratory experiment.

Intervention  Human peritoneal mesothelial cells were harvested from 5 patients undergoing laparotomy and cultured in vitro. Cells were treated with TNF-{alpha}, a cytokine typically involved in peritoneal inflammation, and sodium hyaluronate was added in a final concentration of 0.1%, 0.2%, or 0.4%. Controls received medium only. After 24 hours' incubation, tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), and plasminogen activator inhibitor type 1 (PAI-1) were measured in the medium and cell lysates using enzyme-linked immunosorbent assay techniques. Specific gene transcripts in cells treated with 0.4% sodium hyaluronate and controls were determined using a quantitative reverse transcription polymerase chain reaction.

Main Outcome Measures  Concentrations of tPA, uPA, and PAI-1, and their specific gene transcripts.

Results  Sodium hyaluronate significantly increased tPA concentration in cell lysates without affecting its gene expression as determined after 24 hours (P = .02). The uPA concentration was significantly decreased by sodium hyaluronate in the medium but not in cell lysates (P<.0001). The uPA messenger RNA expression was 1000-fold increased compared with control. Sodium hyaluronate significantly decreased PAI-1 concentration in the medium and reduced its gene expression 500-fold (P = .04), while PAI-1 concentration in cell lysates did not change.

Conclusion  Sodium hyaluronate affected the fibrinolytic response of TNF-{alpha}–stimulated human peritoneal mesothelial cells, most notably by decreasing PAI-1 transcription and release. This observation indicates that sodium hyaluronate counteracts the fibrinolytic decline induced by TNF-{alpha} and suggests a biological mechanism of action for sodium hyaluronate intra-abdominally.


From the Department of Surgery, University Hospital Nijmegen, Nijmegen, the Netherlands (Drs Reijnen and van Goor) and Sahlgrenska University Hospital/Östra, Göteborg University, Göteborg, Sweden (Mr Falk, Ms Hedgren, and Dr Holmdahl).


RELATED ARTICLE

This Month in Archives of Surgery
Arch Surg. 2001;136(3):259.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.